메뉴 건너뛰기




Volumn 15, Issue 5, 2006, Pages 310-311

Montelukast is an effective monotherapy for mild asthma and for asthma with co-morbid allergic rhinitis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BRONCHODILATING AGENT; FLUTICASONE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST;

EID: 33749341805     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.1016/j.pcrj.2006.07.003     Document Type: Letter
Times cited : (8)

References (7)
  • 1
    • 31544444467 scopus 로고    scopus 로고
    • International Primary Care Respiratory Group (IPCRG) Guidelines: Management of Asthma
    • van der Molen T., Ostrem A., Stallberg B., Ostergaard M.S., and Singh R.B. International Primary Care Respiratory Group (IPCRG) Guidelines: Management of Asthma. Prim Care Resp J 15 1 (2006) 35-47
    • (2006) Prim Care Resp J , vol.15 , Issue.1 , pp. 35-47
    • van der Molen, T.1    Ostrem, A.2    Stallberg, B.3    Ostergaard, M.S.4    Singh, R.B.5
  • 2
    • 27944483130 scopus 로고    scopus 로고
    • Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study
    • Garcia Garcia M.L., Wahn U., Gilles L., Swern A., Tozzi C.A., and Polos P. Montelukast, compared with fluticasone, for control of asthma among 6- to 14-year-old patients with mild asthma: the MOSAIC study. Pediatrics 116 (2005) 360-369
    • (2005) Pediatrics , vol.116 , pp. 360-369
    • Garcia Garcia, M.L.1    Wahn, U.2    Gilles, L.3    Swern, A.4    Tozzi, C.A.5    Polos, P.6
  • 3
    • 13544276896 scopus 로고    scopus 로고
    • Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma
    • Bisgaard H., Zielen S., Garcia-Garcia M.L., et al. Montelukast reduces asthma exacerbations in 2- to 5-year-old children with intermittent asthma. Am J Respir Crit Care Med 171 (2005) 315-322
    • (2005) Am J Respir Crit Care Med , vol.171 , pp. 315-322
    • Bisgaard, H.1    Zielen, S.2    Garcia-Garcia, M.L.3
  • 4
    • 0035461065 scopus 로고    scopus 로고
    • Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years
    • Knorr B., Franchi L.M., Bisgaard H., et al. Montelukast, a leukotriene receptor antagonist, for the treatment of persistent asthma in children aged 2 to 5 years. Pediatrics 108 3 (2001) E48
    • (2001) Pediatrics , vol.108 , Issue.3
    • Knorr, B.1    Franchi, L.M.2    Bisgaard, H.3
  • 5
    • 0032522735 scopus 로고    scopus 로고
    • Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group
    • Knorr B., Matz J., Bernstein J.A., et al. Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group. JAMA 279 (1998) 1181-1186
    • (1998) JAMA , vol.279 , pp. 1181-1186
    • Knorr, B.1    Matz, J.2    Bernstein, J.A.3
  • 6
    • 33749366102 scopus 로고    scopus 로고
    • International Primary Care Airways Group (IPAG). Chronic Airways Disease: A Guide for Primary Care Physicians. IPAG Diagnosis & Management Handbook. 2005.
  • 7
    • 31544480665 scopus 로고    scopus 로고
    • International Primary Care Respiratory Group (IPCRG) Guidelines: Management of Allergic Rhinitis
    • Price D., Bond C., Bouchard J., Costa R., Keenan J., Levy M.L., et al. International Primary Care Respiratory Group (IPCRG) Guidelines: Management of Allergic Rhinitis. Prim Care Resp J 15 1 (2006) 58-70
    • (2006) Prim Care Resp J , vol.15 , Issue.1 , pp. 58-70
    • Price, D.1    Bond, C.2    Bouchard, J.3    Costa, R.4    Keenan, J.5    Levy, M.L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.